TFX Teleflex Incorporated
$136.80▲ +0.37%
Healthcare
Other
Pre-market
$137.55▲ +0.55%
Oct 27, 4:02 AM ET
Volume 682.9K
Avg Volume (10D) 654.6K
Key Metrics & Fundamentals
Market Cap
$5.80B
P/E Ratio
2314.8
Div Yield
0.99%
52W Range
100.18 - 145.00
% vs 50 MA
4.53%
% vs 200 MA
9.87%
RSI-14
66.9
MACD Histogram
+1.5900
Beta (1Y vs SPY)
0.63
Free Cash Flow
$80.30M
Gross Rev
$570.33M
Gross Profit
$331.71M
EBITDA
$124.31M
COGS
$238.63M
Operating Exp
$258.64M
Operating Income
$73.07M
EBIT
$73.07M
Pretax Income
$45.14M
Net Income
$99.69M
EPS (Diluted)
2.28
Price & Volume History
Loading chart…
Recent News
Teleflex Wins FDA Breakthrough Designation for Resorbable Heart Scaffold
MT Newswires · Oct 22, 2026 8:52 AM ET
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Business Wire · Oct 22, 2026 6:45 AM ET
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Business Wire · Oct 22, 2026 6:30 AM ET
U.S. Wireless Cardiac Monitoring Systems Market Size, Share, and Forecast 2026-2033 Featuring Profiles of Philips, iRhythm Technologies, Abbott, Medtronic, Biotronik (Teleflex) and More
GlobeNewswire · Oct 20, 2026 5:10 AM ET
1 Value Stock with Exciting Potential and 2 Facing Challenges
StockStory · Oct 19, 2026 8:32 AM ET
Natera Gains 118.1% in a Year: What's Driving the Rally?
Zacks · Oct 15, 2026 8:28 AM ET
Truist Securities Adjusts Teleflex Price Target to $142 From $150, Maintains Hold Rating
MT Newswires · Oct 14, 2026 8:23 AM ET
3 Healthcare Stocks We Find Risky
StockStory · Oct 13, 2026 6:11 AM ET
Teleflex Completes Patient Enrollment for Clinical Study of Freesolve Scaffold in Long Coronary Lesions
MT Newswires · Oct 12, 2026 7:06 AM ET
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Business Wire · Oct 12, 2026 6:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TFX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.